Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson's disease

BMC Medicine

Volumn 9, Issue , 2011, Pages

  Politis, Marios ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

BRAIN REGION; BRAIN TISSUE; CELL TRANSPLANTATION; CLINICAL PROTOCOL; DIGITAL IMAGING; FETUS CELL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAFT SURVIVAL; HUMAN; IN VIVO STUDY; MESENCEPHALIC TRIGEMINAL NUCLEUS; NEUROIMAGING; NEUROTRANSMISSION; NONHUMAN; NOTE; OUTCOME ASSESSMENT; PARKINSON DISEASE; ANIMAL; ARTICLE; BRAIN; CLINICAL TRIAL (TOPIC); DISEASE MODEL; IMAGE PROCESSING; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; TREATMENT OUTCOME;

ANIMALS; BRAIN; CELL TRANSPLANTATION; CLINICAL TRIALS AS TOPIC; DISEASE MODELS, ANIMAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; TREATMENT OUTCOME;

EID: 79955718250     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-9-50     Document Type: Note

References (30)

1. Lindvall O, Hagell P. Clinical observations after neural transplantation in Parkinson's disease. Prog Brain Res 2000, 127:299-320.
2. Brooks DJ. Positron emission tomography imaging of transplant function. NeuroRx 2004, 1:482-491. 10.1602/neurorx.1.4.482, 534954, 15717049.
3. Lindvall O, Björklund A. Cell therapy in Parkinson's disease. NeuroRx 2004, 1:382-393. 10.1602/neurorx.1.4.382, 534947, 15717042.
4. Freeman TB, Olanow CW, Hauser RA, Nauert GM, Smith DA, Borlongan CV, Sanberg PR, Holt DA, Kordower JH, Vingerhoets FJ, Snow BJ, Calne D, Gauger LL. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 1995, 38:379-388. 10.1002/ana.410380307, 7668823.
5. Remy P, Samson Y, Hantraye P, Fontaine A, Defer G, Mangin JF, Fénelon G, Gény C, Ricolfi F, Frouin V, N'Guyen JP, Jeny R, Degos JD, Peschanski M, Cesaro P. Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 1995, 38:580-588. 10.1002/ana.410380406, 7574454.
6. Wenning GK, Odin P, Morrish P, Rehncrona S, Widner H, Brundin P, Rothwell JC, Brown R, Gustavii B, Hagell P, Jahanshahi M, Sawle G, Björklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 1997, 42:95-107. 10.1002/ana.410420115, 9225690.
7. Hagell P, Schrag A, Piccini P, Jahanshahi M, Brown R, Rehncrona S, Widner H, Brundin P, Rothwell JC, Odin P, Wenning GK, Morrish P, Gustavii B, Björklund A, Brooks DJ, Marsden CD, Quinn NP, Lindvall O. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 1999, 122:1121-1132. 10.1093/brain/122.6.1121, 10356064.
8. Brundin P, Pogarell O, Hagell P, Piccini P, Widner H, Schrag A, Kupsch A, Crabb L, Odin P, Gustavii B, Björklund A, Brooks DJ, Marsden CD, Oertel WH, Quinn NP, Rehncrona S, Lindvall O. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 2000, 123:1380-1390. 10.1093/brain/123.7.1380, 10869050.
9. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001, 344:710-719. 10.1056/NEJM200103083441002, 11236774.
10. Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003, 54:403-414. 10.1002/ana.10720, 12953276.
11. Piccini P, Brooks DJ, Björklund A, Gunn RN, Grasby PM, Rimoldi O, Brundin P, Hagell P, Rehncrona S, Widner H, Lindvall O. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 1999, 2:1137-1140. 10.1038/16060, 10570493.
12. Piccini P, Lindvall O, Björklund A, Brundin P, Hagell P, Ceravolo R, Oertel W, Quinn N, Samuel M, Rehncrona S, Widner H, Brooks DJ. Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts. Ann Neurol 2000, 48:689-695. 10.1002/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N, 11079531.
13. Ma Y, Tang C, Chaly T, Greene P, Breeze R, Fahn S, Freed C, Dhawan V, Eidelberg D. Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. J Nucl Med 2010, 51:7-15. 10.2967/jnumed.109.066811, 2946843, 20008998.
14. Politis M, Wu K, Loane C, Quinn NP, Brooks DJ, Rehncrona S, Bjorklund A, Lindvall O, Piccini P. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med 2010, 2:38ra46.
15. Politis M, Oertel WH, Wu K, Quinn NP, Pogarell O, Brooks DJ, Bjorklund A, Lindvall O, Piccini P. Graft-induced dyskinesias in Parkinson's disease: high striatal serotonin/dopamine transporter ratio. Mov Disord
16. Morrish PK, Sawle GV, Brooks DJ. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 1996, 119:585-591. 10.1093/brain/119.2.585, 8800950.
17. Piccini P, Pavese N, Hagell P, Reimer J, Björklund A, Oertel WH, Quinn NP, Brooks DJ, Lindvall O. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005, 128:2977-2986. 10.1093/brain/awh649, 16246865.
18. Kordower JH, Rosenstein JM, Collier TJ, Burke MA, Chen EY, Li JM, Martel L, Levey AE, Mufson EJ, Freeman TB, Olanow CW. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 1996, 370:203-230. 10.1002/(SICI)1096-9861(19960624)370:2<203::AID-CNE6>3.0.CO;2-6, 8808731.
19. Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008, 14:504-506. 10.1038/nm1747, 18391962.
20. Cochen V, Ribeiro MJ, Nguyen JP, Gurruchaga JM, Villafane G, Loc'h C, Defer G, Samson Y, Peschanski M, Hantraye P, Cesaro P, Remy P. Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue. Mov Disord 2003, 18:928-932. 10.1002/mds.10463, 12889084.
21. Pogarell O, Koch W, Gildehaus FJ, Kupsch A, Lindvall O, Oertel WH, Tatsch K. Long-term assessment of striatal dopamine transporters in Parkinsonian patients with intrastriatal embryonic mesencephalic grafts. Eur J Nucl Med Mol Imaging 2006, 33:407-411. 10.1007/s00259-005-0032-z, 16447045.
22. Hagell P, Piccini P, Björklund A, Brundin P, Rehncrona S, Widner H, Crabb L, Pavese N, Oertel WH, Quinn N, Brooks DJ, Lindvall O. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002, 5:627-628.
23. Ma Y, Feigin A, Dhawan V, Fukuda M, Shi Q, Greene P, Breeze R, Fahn S, Freed C, Eidelberg D. Dyskinesia after fetal cell transplantation for Parkinsonism: a PET study. Ann Neurol 2002, 52:628-634. 10.1002/ana.10359, 12402261.
24. Olanow CW, Gracies JM, Goetz CG, Stoessl AJ, Freeman T, Kordower JH, Godbold J, Obeso JA. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: a double blind video-based analysis. Mov Disord 2009, 24:336-343. 10.1002/mds.22208, 19006186.
25. Politis M. Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?. BMC Med 2010, 8:80. 3003184, 21126348.
26. Isacson O, Bjorklund LM, Schumacher JM. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells. Ann Neurol 2003, 53(Suppl 3):135-148.
27. Greicius M. Resting-state functional connectivity in neuropsychiatric disorders. Curr Opin Neurol 2008, 21:424-430.
28. Guye M, Bartolomei F, Ranjeva JP. Imaging structural and functional connectivity: towards a unified definition of human brain organization?. Curr Opin Neurol 2008, 21:393-403.
29. Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci 2009, 10:186-198. 10.1038/nrn2575, 19190637.
30. Ciccarelli O, Catani M, Johansen-Berg H, Clark C, Thompson A. Diffusion-based tractography in neurological disorders: concepts, applications, and future developments. Lancet Neurol 2008, 7:715-727. 10.1016/S1474-4422(08)70163-7, 18635020.